The purpose of this study is to evaluate the effects of treating Obstructive Sleep Apnea (OSA) with continuous positive airway pressure (CPAP) therapy on symptoms of post traumatic stress disorder (PTSD). The study hypotheses are that CPAP use will improve PTSD symptoms overall and that CPAP use will improve sleep quality and duration, nocturnal symptoms related to PTSD, mood, daytime sleepiness, sleep-related quality of life, and general health perception.
Post traumatic stress disorder (PTSD) is associated with increased healthcare utilization, decreased functional status, and overall poor health. Sleep disturbances in PTSD are common, including nightmares, dream enactment, and poor sleep quality. Obstructive sleep apnea (OSA) is also highly prevalent in the veteran population and may exacerbate PTSD symptoms by triggering arousals from sleep that promote recollection of dreams, enactment of dreams, and disrupt sleep continuity. Improvements in sleep quality and PTSD symptoms have been reported when OSA is treated with continuous positive airway pressure (CPAP) therapy. However, formal assessment using validated questionnaires and documentation of CPAP compliance to correlate with these tools has not yet been performed. This study will recruit veterans with PTSD who have been newly diagnosed with OSA and who are willing to try CPAP therapy. Baseline assessments of PTSD symptoms, daytime sleepiness, sleep-related quality of life, sleep quality, general health perception, and mood will be performed before initiation of treatment and after 3 and 6 months of therapy. This study will have the following specific aims: Aim 1: To evaluate the effect of CPAP use on PTSD symptoms. Hypothesis: After 6 months of treatment, CPAP use will improve PTSD symptoms as assessed by the PTSD checklist (PCL-S). Aim 2: To evaluate the effect of CPAP use on 1)sleep quality and duration, 2)nocturnal symptoms of nightmares, movement disorders, dream enactment, and insomnia, 3)mood, 4)daytime sleepiness, 5)sleep-related quality of life, and 6) general health perception. Hypothesis: After 6 months of treatment, CPAP use will improve sleep quality, sleep duration, mood, daytime sleepiness, sleep-related quality of life, general health perception, and nocturnal symptoms of nightmares, movement disorders, dream enactment, and insomnia.
Study Type
OBSERVATIONAL
Enrollment
59
VA San Diego Healthcare System
San Diego, California, United States
Change in PTSD symptoms measured by the PTSD checklist (PCL-S).
A change of -10 points on the PCL-S has been previously determined to be clinically significant.
Time frame: Baseline, 3 months, 6 months
Daytime Sleepiness measured by the Epworth Sleepiness Scale (ESS)
Time frame: Baseline, 3 months, 6 months
Sleep Related Quality of life with be assessed using the Functional Outcomes of Sleep Questionnaire (FOSQ-10).
The FOSQ-10 consists of 10 questions, with a lower score indicating more difficulty with activity due to poor sleep.
Time frame: Baseline, 3 months, 6 months
Change in sleep quality assessed by the Pittsburgh Sleep Quality Index (PSQI).
This is a 19 item self-report assessment of sleep quality and degree of sleep difficulties over the past month. A global score\>/=5 is considered poor sleep quality.
Time frame: Baseline, 3 months, 6 months
Depression will be assessed using the Patient Health Questionnaire-9 (PHQ-9).
The PHQ-9 is a self report depression measure and is a quick, valid assessment of depression. Depression is a common comorbid condition with PTSD.
Time frame: Baseline, 3 months, 6 months
General health related quality of life.
This will be assessed using a likert scale question asking subjects to rate their quality of life for 2 preceding days based on spiritual, emotional, physical, social and financial aspects of their lives.
Time frame: Baseline, 3 months, 6 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.